(2003). Use of alpha-blockers and the risk of hip/femur fractures. J Intern Med.
. A. Egberts
First name
A.
Middle name
C.
Last name
Egberts
(2004). Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart. http://doi.org/10.1136/hrt.2003.020180
. (2005). Risk of hip/femur fractures in patients using antipsychotics. Bone. http://doi.org/10.1016/j.bone.2005.07.005
. (2006). Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy. Neurology. http://doi.org/10.1212/01.wnl.0000210503.89488.88
. (2006). Difference in risks of allergic reaction to sulfonamide drugs based on chemical structure. Ann Pharmacother. http://doi.org/10.1345/aph.1G642
. (2007). Lithium use and the risk of fractures. Bone. http://doi.org/10.1016/j.bone.2006.12.055
. (2008). Psychiatric and cardiovascular comorbidities in patients with diabetes mellitus starting antiobesity drugs. Obesity (Silver Spring). http://doi.org/10.1038/oby.2008.362
. (2014). Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-014-1676-z
. (2014). Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project. Curr Clin Pharmacol.
.